Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34+ progenitor-derived dendritic cells

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

1994 • 5,204 citations

The Dendritic Cell System and its Role in Immunogenicity

1991 • 4,733 citations

Tolerogenic Dendritic Cells

2003 • 3,131 citations

Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

1998 • 2,916 citations

Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

2002 • 2,781 citations

Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma

2001 • 2,658 citations

Mouse and human dendritic cell subtypes

2002 • 2,311 citations

Renal and Extrarenal Effects of Gum Arabic (Acacia Senegal) - What Can be Learned from Animal Experiments?

2013 • 2,289 citations

IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE

1973 • 2,286 citations

Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue

2001 • 1,922 citations

Proliferating dendritic cell progenitors in human blood.

1994 • 1,922 citations

Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

1996 • 1,854 citations

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

1992 • 1,608 citations

Cancer: Principles and Practice of Oncology

1997 • 1,408 citations

Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma

1999 • 1,260 citations

Tumor Antigens Recognized by T Lymphocytes

1994 • 1,238 citations

Adoptive T cell therapy using antigen-specific CD8⁺T cell clones for the treatment of patients with metastatic melanoma:In vivopersistence, migration, and antitumor effect of transferred T cells

2002 • 1,187 citations

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.

1996 • 962 citations

Management of Cutaneous Melanoma

2004 • 830 citations

Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

2001 • 828 citations

Adoptive-cell-transfer therapy for the treatment of patients with cancer

2003 • 656 citations

The use of dendritic cells in cancer immunotherapy

2003 • 641 citations

Cancer vaccines: between the idea and the reality

2003 • 616 citations

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

2002 • 553 citations

Dendritic Cell Vaccines for Cancer Immunotherapy

1999 • 497 citations

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells

1999 • 466 citations

CD34+ Hematopoietic Progenitors From Human Cord Blood Differentiate Along Two Independent Dendritic Cell Pathways in Response to Granulocyte-Macrophage Colony-Stimulating Factor Plus Tumor Necrosis Factor α: II. Functional Analysis

1997 • 442 citations

Cancer vaccines

1998 • 422 citations

Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine

1992 • 410 citations

Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?

2002 • 400 citations

Dendritic Cells as Vectors for Therapy

2001 • 398 citations

Cancer vaccines based on the identification of genes encoding cancer regression antigens

1997 • 395 citations

The Makings of a Tumor Rejection Antigen

1999 • 389 citations

Sequential Biochemotherapy Versus Chemotherapy for Metastatic Melanoma: Results From a Phase III Randomized Trial

2002 • 378 citations

Prognostic Factors in Metastatic Melanoma: A Pooled Analysis of Eastern Cooperative Oncology Group Trials

2000 • 364 citations

Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b

1999 • 318 citations

On Natural and Artificial Vaccinations

2003 • 312 citations

Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy

2002 • 303 citations

Current Developments in Cancer Vaccines and Cellular Immunotherapy

2003 • 300 citations

Antigen Localization and Migration in Immunity and Tolerance

1998 • 280 citations

Tumor-induced immune dysfunction

1999 • 239 citations

Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopes

2000 • 201 citations

Natural T cell immunity against cancer.

2003 • 197 citations

Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma.

1993 • 181 citations

Phase I Trial Of Intravenous Peptide-Pulsed Dendritic Cells in Patients With Metastatic Melanoma

2001 • 171 citations

Survival and Tumor Localization of Adoptively Transferred Melan-A-Specific T Cells in Melanoma Patients

2003 • 163 citations

Rational approaches to human cancer immunotherapy

2003 • 140 citations

Tumor Antigens

1992 • 138 citations

Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma

1992 • 89 citations

Active immunotherapy with allogeneic tumor cell vaccines: present status.

1998 • 89 citations

Textbook of Melanoma

2003 • 85 citations

Virus-Specific CD8 T Cells in Peripheral Tissues Are More Resistant to Apoptosis Than Those in Lymphoid Organs

2003 • 82 citations

Single Injection of CD34+ Progenitor-Derived Dendritic Cell Vaccine Can Lead to Induction of T-Cell Immunity in Patients With Stage IV Melanoma

2003 • 68 citations

Immunogenicity of a polyvalent melanoma antigen vaccine in humans

1988 • 62 citations

Polyvalent Melanoma Vaccine Improves Survival of Patients with Metastatic Melanomaa

1993 • 60 citations

European approach to adjuvant treatment of intermediate- and high-risk malignant melanoma

2002 • 58 citations

Vaccine therapy for patients with melanoma.

1999 • 40 citations

Boosting Vaccinations with Peptide-Pulsed CD34+ Progenitor-Derived Dendritic Cells Can Expand Long-Lived Melanoma Peptide-Specific CD8+ T Cells in Patients with Metastatic Melanoma

2005 • 35 citations

T-cell immunotherapy of cancer

1991 • 28 citations

Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses

2004 • 28 citations

Harnessing T-lymphocytes for human cancer immunotherapy

1985 • 20 citations

The natural history of melanoma and factors predicting outcome

2003 • 7 citations

Cited By (0)

Loading...